Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
DelMar Pharma
503
DelMar Pharma
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Therapeutics
DelMar Pharma ($DMPI) develops #cancer therapies in new indications where patients have failed or are unlikely to respond to modern therapy. #Glioblastoma
Suggest edits
Founded
2010
Raised
$14.6M
Follow us
Also headquartered in Vancouver
Hootsuite
The Next Big Thing
Sierra Wireless
TELUS
Lululemon
Trulioo
Bench
BuildDirect
Indochino
Koho
Companies in the same industry
PeptiMimesis
Fulgent Diagnostics
Myonexus Therapeutics, Inc.
Methylation Sciences
SyntheX
Neos Therapeutics, Inc.
ImmunoBiochem Corporation
Topix Pharmaceuticals, Inc.
Vast Therapeutics
IMMT - Institute of Metagenomics...
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$9,000,000
Post-IPO equity - 2017
$5,600,000
Post-IPO equity - 2016
Team Size
1–10
Employees
I work here
Location
Vancouver
,
Canada
Headquarters
Explore Vancouver
$9,000,000
Post-IPO equity
Drug Delivery Business
DelMar closes $9m public offering
